APA

Scullion G. A., Kendall D. A., Marsden C. A., Sunter D. & Pardon M. (20111122). Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. : Neuropharmacology.

Chicago

Scullion G A, Kendall D A, Marsden C A, Sunter D and Pardon M-C. 20111122. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. : Neuropharmacology.

Harvard

Scullion G. A., Kendall D. A., Marsden C. A., Sunter D. and Pardon M. (20111122). Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. : Neuropharmacology.

MLA

Scullion G A, Kendall D A, Marsden C A, Sunter D and Pardon M-C. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. : Neuropharmacology. 20111122.